The state of play: A Trump-Rubio rematch on China
Among the most vocal critics of President Trump's cave on his trade threats to China is Republican Sen. Marco Rubio, his former opponent on the 2016 campaign trail.
What's happening: A perfect storm of North Korea, Steve Mnuchin and a lack of internal focus has Trump backing away from tariffs against Chinese goods and reportedly floating a deal for rogue Chinese phone maker ZTE. Rubio, one of the co-chairs of the Congressional-Executive Commission on China, is tweeting a steady stream of rebukes of the White House's moves — and hinting that Congress may act to overrule Trump's decisions.
Saturday saw a joint statement from the U.S. and China issued about the ongoing trade war:
- "There was a consensus on taking effective measures to substantially reduce the United States trade deficit in goods with China ... China will significantly increase purchases of United States goods and services."
- "Both sides agreed to encourage two-way investment and to strive to create a fair, level playing field for competition."
The next day, Treasury Secretary Steve Mnuchin made things clearer on Fox News Sunday:
- "We're putting the trade war on hold, so right now we have agreed to put the tariffs on hold while we try to execute the framework."
And today, The Wall Street Journal reported that Chinese phonemaker ZTE had become part of the deal:
- "The U.S. and China have agreed on the broad outline of a deal that would save imperiled Chinese telecom giant ZTE Corp."
- The background: The Commerce Department's ban that killed ZTE was put in place due to the company's repeated violations of U.S. sanctions against Iran and North Korea. The Pentagon has also banned ZTE's phones from retail outlets on U.S. military bases due to concerns from intelligence agencies that the Chinese are using its devices to spy on Americans.
Rubio on ZTE
Rubio on the China moves
Go deeper: Rubio told Axios earlier this month that the U.S. can't remain silent on Chinese human rights violations in order to secure a better trade deal.